1485 related articles for article (PubMed ID: 17063274)
41. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
Kim JS; Lee SM; Cha ES
Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic accuracy of high-resolution MRI using a microscopy coil for patients with presumed DCIS following mammography screening.
Zhu J; Kurihara Y; Kanemaki Y; Ogata H; Fukuda M; Nakajima Y; Maeda I
J Magn Reson Imaging; 2007 Jan; 25(1):96-103. PubMed ID: 17154376
[TBL] [Abstract][Full Text] [Related]
43. Can magnetic resonance imaging obviate the need for biopsy for microcalcifications?
Yamamoto S; Chishima T
Gland Surg; 2017 Aug; 6(4):302-307. PubMed ID: 28861368
[TBL] [Abstract][Full Text] [Related]
44. BI-RADS Category 5 Assessments at Diagnostic Breast Imaging:Outcomes Analysis Based on Lesion Descriptors.
Yao MM; Joe BN; Sickles EA; Lee CS
Acad Radiol; 2019 Aug; 26(8):1048-1052. PubMed ID: 30195413
[TBL] [Abstract][Full Text] [Related]
45. Cost-effectiveness of stereotactic vacuum-assisted biopsy for nonpalpable breast lesions.
Tsai HY; Huang ST; Chao MF; Kan JY; Hsu JS; Hou MF; Chiu HC
Eur J Radiol; 2020 Jun; 127():108982. PubMed ID: 32334370
[TBL] [Abstract][Full Text] [Related]
46. Differentiation of benign from malignant breast disease associated with screening detected microcalcifications using dynamic contrast enhanced magnetic resonance imaging.
Kneeshaw PJ; Lowry M; Manton D; Hubbard A; Drew PJ; Turnbull LW
Breast; 2006 Feb; 15(1):29-38. PubMed ID: 16002292
[TBL] [Abstract][Full Text] [Related]
47. Accuracy and outcomes of stereotactic vacuum-assisted breast biopsy for diagnosis and management of nonpalpable breast lesions.
Tsai HY; Chao MF; Ou-Yang F; Kan JY; Hsu JS; Hou MF; Chiu HC
Kaohsiung J Med Sci; 2019 Oct; 35(10):640-645. PubMed ID: 31271510
[TBL] [Abstract][Full Text] [Related]
48. Screening breast MR imaging: comparison of interpretation of baseline and annual follow-up studies.
Abramovici G; Mainiero MB
Radiology; 2011 Apr; 259(1):85-91. PubMed ID: 21285337
[TBL] [Abstract][Full Text] [Related]
49. Dual-Energy Contrast-Enhanced Spectral Mammography: Enhancement Analysis on BI-RADS 4 Non-Mass Microcalcifications in Screened Women.
Cheung YC; Juan YH; Lin YC; Lo YF; Tsai HP; Ueng SH; Chen SC
PLoS One; 2016; 11(9):e0162740. PubMed ID: 27611215
[TBL] [Abstract][Full Text] [Related]
50. BI-RADS categorization as a predictor of malignancy.
Orel SG; Kay N; Reynolds C; Sullivan DC
Radiology; 1999 Jun; 211(3):845-50. PubMed ID: 10352614
[TBL] [Abstract][Full Text] [Related]
51. Detection and diagnosis of automated breast ultrasound in patients with BI-RADS category 4 microcalcifications: a retrospective study.
Yu LF; Dai CC; Zhu LX; Xu XJ; Yan HJ; Jiang CX; Bao LY
BMC Med Imaging; 2024 May; 24(1):126. PubMed ID: 38807064
[TBL] [Abstract][Full Text] [Related]
52. Bayesian network to predict breast cancer risk of mammographic microcalcifications and reduce number of benign biopsy results: initial experience.
Burnside ES; Rubin DL; Fine JP; Shachter RD; Sisney GA; Leung WK
Radiology; 2006 Sep; 240(3):666-73. PubMed ID: 16926323
[TBL] [Abstract][Full Text] [Related]
53. Clinical implications of subcategorizing BI-RADS 4 breast lesions associated with microcalcification: a radiology-pathology correlation study.
Sanders MA; Roland L; Sahoo S
Breast J; 2010; 16(1):28-31. PubMed ID: 19929890
[TBL] [Abstract][Full Text] [Related]
54. [Percutaneous stereotactic biopsy of non-palpable breast lesions using the Advanced Breast Biopsy Instrumentation (ABBI) system: critical evaluation of indication strategies].
Wedegärtner U; Otto U; Buitrago-Tellez C; Bremerich J; Oertli D; Torhorst J; Bongartz G
Rofo; 2001 Mar; 173(3):224-8. PubMed ID: 11293864
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of the stereotactic 8G vacuum-assisted breast biopsy in the histologic evaluation of suspicious mammography findings (BI-RADS IV).
Diebold T; Hahn T; Solbach C; Rody A; Balzer JO; Hansmann ML; Marx A; Viana F; Peters J; Jacobi V; Kaufmann M; Vogl TJ
Invest Radiol; 2005 Jul; 40(7):465-71. PubMed ID: 15973139
[TBL] [Abstract][Full Text] [Related]
56. Computer-aided classification of BI-RADS category 3 breast lesions.
Buchbinder SS; Leichter IS; Lederman RB; Novak B; Bamberger PN; Sklair-Levy M; Yarmish G; Fields SI
Radiology; 2004 Mar; 230(3):820-3. PubMed ID: 14739315
[TBL] [Abstract][Full Text] [Related]
57. Scoring System to Stratify Malignancy Risks for Mammographic Microcalcifications Based on Breast Imaging Reporting and Data System 5th Edition Descriptors.
Youk JH; Gweon HM; Son EJ; Eun NL; Choi EJ; Kim JA
Korean J Radiol; 2019 Dec; 20(12):1646-1652. PubMed ID: 31854152
[TBL] [Abstract][Full Text] [Related]
58. Unveiling the potential of breast MRI: a game changer for BI-RADS 4A microcalcifications.
Li S; Lin Y; Liu G; Shao Z; Yang Y
Breast Cancer Res Treat; 2024 Jul; 206(2):425-435. PubMed ID: 38664289
[TBL] [Abstract][Full Text] [Related]
59. Positive predictive value of breast cancer in the lesions categorized as BI-RADS category 5.
Wiratkapun C; Lertsithichai P; Wibulpholprasert B
J Med Assoc Thai; 2006 Aug; 89(8):1253-9. PubMed ID: 17048437
[TBL] [Abstract][Full Text] [Related]
60. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.
Fenlon HM; Phelan NC; O'Sullivan P; Tierney S; Gorey T; Ennis JT
Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
